An overview of three decades of research in pediatric psychopharmacoepidemiology

Journal of Child and Adolescent Psychopharmacology

Volumn 7, Issue 4, 1997, Pages 219-236

  Gadow, Kenneth D ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ATTENTION DEFICIT DISORDER; AUTISM; CHILD PSYCHIATRY; CLINICAL RESEARCH; DEPRESSION; DRUG INDICATION; DRUG USE; ENURESIS; GILLES DE LA TOURETTE SYNDROME; HUMAN; MENTAL DEFICIENCY; PEDIATRICS; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PREVALENCE; PSYCHOPHARMACOLOGY; REVIEW; SEIZURE;

EID: 0031419452     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.1997.7.219     Document Type: Review

References (97)

1. Abramowicz M (ed): Sudden death in children treated with a tricyclic antidepressant. Medical Letter Drugs Therapeutics 32:53-54, 1990
2. Ahsanuddin KM, Ivey JA, Schlotzhauer D, Hall K, Prosen H: Psychotropic medication prescription patterns in 100 hospitalized children and adolescents. J Amer Acad Child Psychiatry 22:361-364, 1983
3. Alvarez N: Discontinuance of antiepileptic medications in patients with developmental disability and diagnosis of epilepsy. Am J Mental Retardation 93:593-599, 1989
4. Aman MG, Field CJ, Bridgman GD: City-wide survey of drug patterns among non-institutionalized retarded persons. Appl Res Mental Retardation 6:159-171, 1985
5. Aman MG, Marks RE, Turbott SH, Wilsher CP, Merry SN: Clinical effects of methylphenidate and thioridazine in intellectually subaverage children. J Amer Acad Child Adolesc Psychiatry 30:246-251, 1991a
6. Aman MG, Singh NN (eds): Psychopharmacotherapy of the Developmental Disabilities. New York, Springer-Verlag, 1988
7. Aman MG, Van Bourgodien ME, Wolford PL, Sarphare G: Psychotropic and anticonvulsant drugs in subjects with autism: Prevalence and patterns of use. J Amer Acad Child Adolesc Psychiatry 34:1672-1681, 1995
8. Barkley RA, Fischer M, Newby RF, Breen MJ: Development of a multimethod clinical protocol for assessing stimulant drug response in children with attention deficit disorder. J Clin Child Psychol 17:14-24, 1988
9. Beghi E, Bollini P, DiMascio R, Cerisola N, Merloni T, Manghi E: Effects of rationalizing drug treatment of patients with epilepsy and mental retardation. Devel Med Child Neurol 29:363-369, 1987
10. Bennett FC, Sherman R: Management of childhood "hyperactivity" by primary care physicians. J Devel Behav Pediatrics 4:88-93, 1983
11. Biederman J: Sudden death in children treated with a tricyclic antidepressant. J Amer Acad Child Adolesc Psychiatry 30:495-198, 1991
12. Bosco JJ, Robin SS: Ritalin usage: A challenge to teacher education. Peabody J Education 53:187-193, 1976
13. Brulle AR, Barton LE, Foskett JJ: Educator/physician interchanges: A survey and suggestions. Education and Training of the Mentally Retarded 18:313-317, 1983
14. Cohen NJ, Sullivan S, Minde K, Novak C, Helwig C: Evaluation of the relative effectiveness of methylphenidate and cognitive behavior modification in the treatment of kindergarten-aged hyperactive children. J Abn Child Psychol 9:43-54, 1981
15. Collacott RA, Dignon A, Hauck A, Ward JW: Clinical and therapeutic monitoring of epilepsy in a mental handicap unit. Brit J Psychiatry 155:522-525, 1989
16. Conners CK: Controlled trial of methylphenidate in preschool children with minimal brain dysfunction. Intl J Mental Health 4:61-74, 1975
17. Copeland L, Wolraich M, Lindgren S, Milich R, Woolson R: Pediatricians' reported practices in the assessment and treatment of attention deficit disorders. J Devel Behav Pediatrics 8:191-197, 1987
18. Cullinan D, Gadow KD, Epstein MH: Psychotropic drug treatment among learning disabled, mentally retarded, and seriously emotionally disturbed students. J Abn Child Psychol 15:469-477, 1987
19. Devinsky O: Cognitive and behavioral effects of antiepileptic drugs. Epilepsia 36(Suppl 2):S46-S65, 1995
20. Deykin EY, MacMahon B: The incidence of seizures among children with autistic symptoms. Amer J Psychiatry 126:1310-1312, 1979
21. Divoky D: Toward a nation of sedated children. Learning 1:7-13, 1973
22. Emerson R, D'Souza BJ, Vining EP, Holden KR, Mellits ED, Freeman JM: Stopping medication in children with epilepsy. NEJM 304:1125-1129, 1981
23. Fine S, Jewesson B: Active drug placebo trial of methylphenidate: A clinical service for children with an attention deficit disorder. Canad J Psychiatry 34:447-449, 1989
24. Foxman B, Valdez RB, Brook RH: Childhood enuresis: Prevalence, perceived impact, and prescribed treatments. Pediatrics 77:482-487, 1986
25. Gadow KD: Pills and preschool: Medication usage with young children in special education [Abstract]. Presented at the meeting of the Illinois Council for Exceptional Children, Chicago, October 1975
26. Gadow KD: Psychotropic and anticonvulsant drug usage in early childhood special education programs. 1. Phase One: A preliminary report: Prevalence, attitude, training and problems [Abstract]. Paper presented at the annual meeting of the Council for Exceptional Children, Chicago, April 1976 [ERIC Document Reproduction Service No. ED 125 198]
27. Gadow KD: Psychotropic and antiepileptic drug treatment in early childhood special education. Champaign (IL), Institute for Child Behavior and Development, 1977 [ERIC Document Reproduction Service No. ED 162 494]
28. Gadow KD: Psychotropic and antiepileptic drug treatment in programs for the trainable mentally handicapped (Doctoral dissertation, University of Illinois at Urbana-Champaign). Dissertation Abstracts International 39:2866-A, 1978 [University Microfilms No. 7820938]
29. Gadow KD: Prevalence of drug treatment for hyperactivity and other childhood behavior disorders. In: Psychosocial Aspects of Drug Treatment for Hyperactivity. Edited by Gadow KD, Loney J. Boulder, CO, Westview Press, 1981, pp 13-76
30. Gadow KD: School involvement in the treatment of seizure disorders. Epilepsia 23:215-224, 1982
31. Gadow KD: School involvement in pharmacotherapy for behavior disorders. J Special Education 16:385-399, 1982
32. Gadow KD: Pediatric psychopharmacotherapy: A review of recent research. J Child Psychol Psychiatry 33:153-195, 1992
33. Gadow KD: Pharmacotherapy for behavior disorders: Typical treatment practices. Clin Pediatrics 22:48-53, 1983
34. Gadow KD, Kalachnik J: Prevalence and pattern of drug treatment for behavior disorders of TMR students. Amer J Mental Deficiency 85:588-595, 1981
35. Gadow KD, Nolan EE, Paolicelli LM, Sprafkin J: A procedure for assessing the effects of methylphenidate on hyperactive children in public school settings. J Clin Child Psychol 20:268-276, 1991
36. Gadow KD, Poling AD: Pharmacotherapy and mental retardation. Austin (TX), PRO-ED, 1988
37. Gadow KD, Sprafkin J: ADHD Symptom Checklist-4 Manual. Stony Brook, NY, Checkmate Plus, 1997
38. Gates D: Just saying no to Ritalin. Newsweek, November 23, 1987, p. 6
39. Gillberg C: The treatment of epilepsy in autism. J Autism Develop Disord 21:61-77, 1991
40. Greiner T: Problems of methodology in research with drugs. Amer J Mental Deficiency 64:346-352, 1958
41. Gualtieri CT, Sprague RL, Cole JO: Tardive dyskinesia litigation and the dilemmas of neuroleptic treatment. J Psychiatry Law 14:187-216, 1986
42. Handen BL, Breaux AM, Gosling A, Ploof DL, Feldman D: Effectiveness of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder. Pediatrics 86:922-930, 1990
43. Hauser WA, Hesdorffer DC: Epilepsy: Frequency, Causes, and Consequences. New York, Demos, 1990
44. Hentoff N: The drugged classroom. Evergreen Review, December 1970, pp 31-33
45. Hill BK, Balow EA, Bruininks RH: A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people. Psychopharmacol Bull 21:279-284, 1985
46. Hill BK, Lakin KC, Bruininks RH: Trends in residential services for mentally retarded people: 1977-1982. Journal of the Association of Persons with Severe Handicaps 9:243-250, 1984
47. Holowach J, Thurstone DL, O'Leary J: Prognosis in childhood epilepsy: Follow-up study of 148 cases in which therapy had been suspended after prolonged anticonvulsant control. NEJM 286:169-174, 1972
48. Jensen PS, Vitiello B, Leonard H, Laughren TP: Child and adolescent psychopharmacology: Expanding the research base. Psychopharmacol Bull 30:3-8, 1994
49. Jensen PS, Xenakis SN, Shervette RE, Bain MW, Davis H: Diagnosis and treatment of attention deficit disorder in two general hospital clinics. Hosp Commun Psychiatry 40:708-712, 1989
50. Johnson P: Family: Remedy led to "hell." USA Today, April 27, 1988
51. Kaplan SL, Busner J: Prescribing practices of inpatient child psychiatrists in three auspices of care. J Child Adolesc Psychopharmacol 7:275-286, 1997
52. Kaplan SL, Simms RM, Busner J: Prescribing practices of outpatient child psychiatrists. J Am Acad Child Adolesc Psychiatry 33:35-44, 1994
53. Keller MB, Klerman GL, Lavori PW, Fawcett JA, Coryell W, Endicott J: Treatment received by depressed patients. JAMA 248:1848-1855, 1982
54. Keller MB, Lavori PW, Beardslee WR, Wunder J, Ryan N: Depression in children and adolescents: New data on "undertreatment" and a literature review on the effectiveness of available treatments. J Affective Disorders 21:163-171, 1991
55. Kovacs M, Feinberg TL, Crouse-Novak MA, Paulauskas SL, Finkelstein R: Depressive disorders in childhood: I. A longitudinal prospective study of characteristics and recovery. Arch Gen Psychiatry 41:229-237, 1984
56. Ladd ET: Pills for classroom peace. Saturday Review, November 21, 1970, pp 66-68, 81-83
57. Lasagna L: A plea for the "naturalistic" study of medicine [editorial]. Eur J Clin Pharmacol 7:153, 1974
58. LeFever GB, Hannon PH, Dawson KV, Morrow RC, Morrow AL: Prevalence of medication use for attention deficit hyperactivity disorder (ADHD): A population-based study of Virginia school children [abstract]. Pediatric Res 41:14A, 1997
59. Loney J, Ordona TT: Using cerebral stimulants to treat minimal brain dysfunction. Am J Orthopsychiatry 45:564-572, 1975
60. Maynard R: Omaha pupils given "behavior" drugs. Washington Post, June 29, 1970
61. Miller FJW: Children who wet the bed. In: Clinics in Developmental Medicine: Bladder Control and Enuresis. Edited by Kolvin I, MacKeith RC, Meadow SR. Washington Square, PA, Lippincott, 1973, pp 47-57
62. Miller K, Atkin B, Moody ML: Drug therapy for nocturnal enuresis: Current treatment recommendations. Drugs 44:47-56, 1992
63. Pelham WE, Hoza J: Behavioral assessment of psychostimulant effects on ADD children in a summer day treatment program. In: Advances in Behavioral Assessment of Children and Families, Volume 3. Edited by Prinz R. Greenwich, CT, JAI Press, 1987, pp 3-34
64. Pietsch S (ed): The Person with Epilepsy: Life Styles, Needs, Expectations. Chicago, IL, National Epilepsy League, 1977
65. Popper CW, Elliott GR: Sudden death and tricyclic antidepressants: Clinical considerations for children. J Child Adolesc Psychopharmacol 1:125-132, 1990
66. Popper CW, Zimnitzky B: Sudden death putatively related to desipramine treatment in youth: A fifth case and a review of speculative mechanisms. J Child Adolesc Psychopharmacol 5:283-300, 1995
67. Rappley MD, Gardiner JC, Jetton JR, Houang RT: The use of methylphenidate in Michigan. Arch Pediatr Adolesc Med 149:675-679, 1995
68. Riddle MA, Nelson JC, Kleinman CS, Rasmusson A, Leckman JF, King RA, Cohen DJ: Sudden death in children receiving Norpramin®: A review of three reported cases and commentary. J Am Acad Child Adolesc Psychiatry 30:104-108, 1991
69. Rimland B: Controversies in the treatment of autistic children: Vitamin and drug therapy. J Child Neurology 3 (Suppl.):S68-S72, 1988
70. Rogers JM: Drug abuse: Just what the doctor ordered. Psychology Today, September 1971, pp 16-24
71. Safer DJ: Patterns of psychotropic medication prescribed by child psychiatrists in the 1990s. J Child Adolesc Psychopharmacol 7:267-274, 1997
72. Safer DJ, Allen RP: Absence of tolerance to the behavioral effects of methylphenidate in hyperactive and inattentive children. J Pediatr 115:1003-1008, 1989
73. Safer DJ, Krager JM: A survey of medication treatment for hyperactive/inattentive students. JAMA 260:2256-2258, 1988
74. Safer DJ, Krager JM: Hyperactivity and inattentiveness: School assessment of stimulant treatment. Clin Pediatr 28:216-221, 1989
75. Safer DJ, Krager JM: Effect of a media blitz and a threatened law suit on stimulant treatment. JAMA 268:1004-1007, 1992
76. Safer DJ, Krager JM: The increased rate of stimulant treatment for hyperactive/inattentive students in secondary schools. Pediatrics 94:462-464, 1994
77. Safer DJ, Zito JM, Fine EM: Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 98:1084-1088, 1996
78. Sandoval J, Lambert N, Yandell W: Current medical practice and hyperactivity. Am J Orthopsychiatry 46:323-334, 1976
79. Schleifer M, Weiss G, Cohen N, Elman M, Cvejic H, Kruger E: Hyperactivity in preschoolers and the effect of methylphenidate. Am J Orthopsychiatry 45:38-50, 1975
80. Schmidt WE: Sales of drugs are soaring for treatment of hyperactivity. New York Times, May 5, 1987
81. Sindelar PT, Meisel CJ: Teacher-physician interaction in the treatment of children with behavioral disorders. Intl J Partial Hospitalization 1:271-277, 1982
82. Singh NN, Ellis CR, Wechsler H: Psychopharmacoepidemiology of mental retardation. J Child Adolesc Psychopharmacol 7:255-266, 1997
83. Sivenius J, Savolainen S, Kaski M, Riekkinen PJ: Therapeutic intervention in mentally retarded adult epileptics. Acta Neurol Scand 81:165-167, 1990
84. Sleator EK, von Neumann A: Methylphenidate in the treatment of hyperkinetic children. Clin Pediatrics 13:19-24, 1974
85. Solomons G: Drug therapy: Initiation and follow-up. Ann NY Acad Sci 205:335-344, 1973
86. Sprafkin J, Gadow KD: Double-blind versus open evaluations of stimulant drug response in children with attention-deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 6:215-228, 1996
87. Sprague RL: Litigation, legislation, and regulations. In: Drugs and Mental Retardation. Edited by Breuning SE, Poling AD. Springfield, IL, Charles C. Thomas, 1982, pp 377-414
88. Sprague RL, Gadow KD: The role of the teacher in drug treatment. School Review 85:109-140, 1976
89. Sprague RL, Galliher L: Litigation about psychotropic medication. In: Pharmacotherapy and Mental Retardation. Edited by Gadow KD, Poling AD. Austin, TX, PRO-ED, 1988, pp 297-312
90. Sprague RL, Sleator E: Effects of psychopharmacological agents on learning disorders. Pediatric Clin North America 20:719-735, 1973
91. Stefl ME, Bornstein RA, Hammond L: The 1987 Ohio Tourette survey. Milford, OH, Tourette Syndrome Association of Ohio, 1988
92. Stephen K, Sprague RL, Werry J: Drug treatment of hyperactive children in Chicago (Progress Report of NIMH Grant No. MH 18909, 1970-1973, R.L. Sprague, Principal Investigator). Urbana, IL, Children's Research Center, 1973
93. Strom BL: What is pharmacoepidemiology? In: Pharmacoepidemiology. Edited by Strom BL. New York, Churchill Livingstone, 1989
94. Todt H: The late prognosis of epilepsy in childhood: Results of a prospective follow-up study. Epilepsia 25:137-144, 1984
95. Volkmar FR, Nelson DS: Seizure disorders in autism. J Am Acad Child Adolesc Psychiatry 29:127-129, 1990
96. Weithorn CJ, Ross R: Who monitors medication? J Learning Disabilities 8:458-461, 1975
97. Zito JM, Safer J: Sources of data for pharmacoepidemiological studies of child and adolescent psychiatric disorders. J Child Adolesc Psychopharmacol 7:237-253, 1997